Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor

Roth, 1985, Ovarian Brenner tumors. I. Metaplastic, proliferating, and of low malignant potential, Cancer, 56, 582, 10.1002/1097-0142(19850801)56:3<582::AID-CNCR2820560327>3.0.CO;2-E

Baker, 2003, Brenner tumor of the ovary with striking microcystic change, Int J Gynecol Pathol, 22, 185, 10.1097/00004347-200304000-00012

Lee, 2003, Tumors of the ovary and peritoneum, 113

Scully, 1998

Seidman, 2008, Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors, Arch Pathol Lab Med, 132, 1753, 10.5858/132.11.1753

Kuhn, 2013, Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium, Eur J Cancer, 49, 3839, 10.1016/j.ejca.2013.08.011

Roma, 2014, Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity for PAX2, PAX8, and GATA-3, Int J Gynecol Pathol, 33, 624, 10.1097/PGP.0000000000000088

Roma, 2014, Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study, Hum Pathol, 10.1016/j.humpath.2014.08.003

Grote, 2006, Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney, Development, 133, 53, 10.1242/dev.02184

Esheba, 2009, Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations, Am J Surg Pathol, 33, 347, 10.1097/PAS.0b013e3181908e24

Waxman, 1979, Pure and mixed Brenner tumors of the ovary: clinicopathologic and histogenetic observations, Cancer, 43, 1830, 10.1002/1097-0142(197905)43:5<1830::AID-CNCR2820430536>3.0.CO;2-C

Kondi-Pafiti, 2012, Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors, Arch Gynecol Obstet, 285, 1699, 10.1007/s00404-011-2182-5

Liliac, 2013, The value of PAX8 and WT1 molecules in ovarian cancer diagnosis, Rom J Morphol Embryol, 54, 17

Laury, 2011, A comprehensive analysis of PAX8 expression in human epithelial tumors, Am J Surg Pathol, 35, 816, 10.1097/PAS.0b013e318216c112

Tong, 2009, Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study, Mod Pathol, 22, 1218, 10.1038/modpathol.2009.88

Bowen, 2007, Emerging roles for PAX8 in ovarian cancer and endosalpingeal development, Gynecol Oncol, 104, 331, 10.1016/j.ygyno.2006.08.052

Köbel, 2008, Ovarian carcinoma subtypes are different diseases: implications for biomarker studies, PLoS Med, 5, e232, 10.1371/journal.pmed.0050232

Nonaka, 2008, Expression of PAX8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas, Am J Surg Pathol, 32, 1566, 10.1097/PAS.0b013e31816d71ad

Ozcan, 2011, PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study, Mod Pathol, 24, 751, 10.1038/modpathol.2011.3